Abstract
1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.
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To cite this version: where Th1-polarized DC are first generated whereas the same cells analyzed at later time points of maturation stop secreting IL-12 and prime Th2 and non polarized cells (28).
IDO can be induced in vitro or in vivo by various agents like cytokines (IFNγ, TNFα), CD40L, CTLA4-Ig, influenza virus or bacterial LPS (32) (33) (34) (35) (36) (37) . Several subsets of IDOexpressing DC have been described. CD11c + murine DC express IDO protein but enzyme activity is only detected in the CD8 + subset (38) . In mice, plasmacytoid DC that express IDO can inhibit T cell responses (39, 40). A particular subset of human myeloid DC expressing CCR6, CD123 and a constitutively active form of IDO is deficient for T cell stimulation and may thus play a central role in tolerance (21) . Another group has shown that human monocyte-derived DC expressing active IDO after IFNγ stimulation do not suppress T cell proliferation (41). Therefore, further studies will be necessary to describe the different functions of human DC expressing IDO (42). Moreover, some studies suggest that IDO is necessary for DC activation (43).
In previous in vitro experiments, 1-MT was added in cocultures of DC with T cells to study the role of IDO on T cell proliferation and activation (18, 19, 24) . Since DC maturation is a crucial step to control immune responses, we analyzed the direct effect of 1-MT on the maturation of human monocyte-derived DC. It is shown that 1-MT affected differentially the function of DC depending on the quality of the maturation signal. In the presence of 1-MT, pIC-stimulated DC maintained their capacity to induce a Th1 response while DC stimulated with TLR2 ligands had an increased ability to stimulate IFNγ secretion by T cells. In contrast, 1-MT on TLR4-stimulated DC reoriented DC toward a Th2 function, a process involving both ERK and p38-MAPK. Interestingly, all these effects of 1-MT were not correlated to the inhibition of IDO activity.
HAL author manuscript inserm-00137240, version 1
This is an author-produced version of a manuscript accepted for publication in The Journal of Immunology (The JI FITC-conjugated anti-CD14, -HLA-DR, -CD80, -CD54, and PE-conjugated anti-CD1a, -CD86, -CD83 and -CD40 (Beckman Coulter) .
Cytokine assay
Culture supernatants were stored at -80°C. IL-6, IL-10, IL-1β, TNFα and IL-13 levels were determined using cytokine-specific ELISA kits (Endogen, Woburn, MA, USA). IL-12 p40 and p70 were assayed using ELISA kits from Biosource (Camarillo, CA, USA). IL-2, IL-4, IL-5, IL-10 and IFNγ were determined using the human Th1-Th2 cytokine CBA kit I (BD Biosciences).
Mixed Lymphocyte Reaction
T lymphocytes were purified after Ficoll-Hypaque and Percoll gradient centrifugation by immunomagnetic depletion using a cocktail of monoclonal Ab anti-CD19 (4G7), anti-CD56 (NKH1), anti-CD16 (3G8), anti-CD14 (RMO52) and anti-glycophorin A (11E4B7.6) (Beckman Coulter). T lymphocytes were more than 95% pure as assessed by CD3 labeling.
Primary MLR were conducted in 96-well flat-bottom culture plates. DC recovered at day 7
were extensively washed and resuspended in complete RPMI 1640 / 10% FCS. Cells were cocultured in triplicates with 2. 
T cell response against tetanus toxin
DC were treated as for MLR and autologous CD3 T cells were purified as described above from frozen PBL. DC recovered at day 7 were extensively washed and resuspended in IFNγ measurement. Tetanus neurotoxin has no effect on DC or T cells alone (data not shown).
Intracellular staining of cytokines
MLR were conducted for 5 days and T cells were expanded for 7 days with 25 U/ml rhIL-2 (Biosource), washed and restimulated with 10 ng/ml PMA (Sigma-Aldrich) and 1 µg/ml ionomycin (VWR International, Fontenay-sous-Bois, France) for 5 h. 10 ng/ml Brefeldin A (Sigma-Aldrich) was added during the last 2 h. Cells were fixed and permeabilized using Cytofix/Cytoperm kit (BD Biosciences). Intracellular staining was performed using FITClabeled anti-IFNγ monoclonal Ab and PE-labeled anti-IL-5 and IL-13 monoclonal Ab (BD Biosciences).
IDO expression and activity
Total RNA was extracted from cells collected at day 7 using RNeasy Mini kit (Qiagen, Courtaboeuf, France). 100 ng of total RNA was reverse transcribed using the thermoscript RT-PCR system (Life Technologies). Primers used for PCR amplification are: 5'-GCTTTCACACAGGCGTCATA-3' and 5'-GGTCATGGAGATGTCCGTAA-3' for IDO, and 5'-GGAGGTGTAATGGACGTTA-3' and 5'-CTGAGACTCCTTGCCATAG-3' for S12.
The amplified products were analyzed by gel electrophoresis (691 bp for IDO and 311 bp for S12).
Trp is converted by IDO to N-formylkynurenine which is further catabolized to kynurenine.
Quantification of kynurenine in supernatants thus reflects IDO activity. Kynurenine was measured in fresh supernatants of DC collected at day 7 as described previously (44). Briefly, 
Results

The effect of 1-MT on DC is dependent on the maturation signal
To test the action of 1-MT on DC maturation, DC were treated with 1-MT 24 h before TLR stimulation. LPS was used as a prototype of TLR4 ligand, pIC for TLR3 stimulation, and 
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The effect of 1-MT can also be observed in a recall response
Since allogeneic MLR does not reflect an antigen-specific response, we examined the effect of 1-MT treatment of DC in an autologous response to tetanus neurotoxin. As shown in figure   2 , the results found in allogeneic MLR can be observed in an antigen specific response. 
Effect of 1-MT on phenotypic maturation and cytokine secretion by DC
DC stimulated by LPS, pIC or PGN showed a classic phenotype of mDC with a strong induction of CD86 and CD40 ( Fig. 3) as well as CD80, CD83 and HLA-DR (data not shown).
Pam was a weaker inducer of phenotypic maturation of DC. 1-MT pre-treatment had no effect on phenotypic maturation induced by pIC or Pam. Obvious effects of 1-MT were observed when DC maturation was induced by PGN and LPS. Indeed, for PGN-or LPS-matured DC, the expression of maturation markers was reduced by 1-MT pre-treatment although these markers were still expressed at high level ( (table II) . As expected, LPS and PGN were strong inducers of all the cytokines tested, except for IL-12p70 which was only induced by LPS. 1-MT pre-treatment of LPS or PGN-stimulated DC was characterized by a strong reduction in secretion of IL-6, IL-10, IL-12p70 and TNFα (table II) . In all conditions, cells remained negative for IFNγ and IL-1β secretion and DC viability was not modified (data not shown). 1-MT alone did not affect the basal level of cytokine secretion by iDC (table II) .
The overall data indicate that 1-MT pre-treatment of DC can interfere with the phenotypic maturation and the cytokine secretion depending on TLR signaling.
Inhibition of IDO activity is not sufficient to change DC polarization
IDO mRNA was weakly detected in iDC while LPS, pIC and PGN strongly increased its 
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Kynurenine is the main catabolite of Trp and is involved in the inhibition of T cell proliferation (18, 22) . Since its production is inhibited by 1-MT, we asked whether addition of kynurenine during the pre-treatment of DC with 1-MT could restore a normal phenotypic and functional maturation induced by LPS. Figure 4C shows that kynurenine had no effect on the allostimulatory function of LPS-stimulated DC and could not inhibit the Th2 shift induced by 1-MT. Kynurenine had no effect on phenotypic maturation and cytokine secretion of LPSstimulated DC ( suppressed by an excess of Trp that could displace 1-MT from the enzyme (Fig. 4C ).Thus all these results strongly suggest that the effect of 1-MT on TLR signaling in DC is independent of IDO activity.
p38-MAPK, ERK and c-Fos in DC polarization
p38-MAPK and ERK have been shown to play a role in DC maturation and in the type of T cell response they can elicit (45-48). We thus asked whether these pathways could be differentially engaged when DC were pre-treated with 1-MT before activation with the different TLR ligands. The functional consequences of specific inhibitors of these two kinases on DC maturation was therefore examined. SB203580 (SB) is a specific inhibitor of p38-MAPK and PD98059 (PD) inhibits MEK activation thus preventing ERK phosphorylation. suggesting that the MEK/ERK pathway is not essential in LPS-induced maturation (Fig. 5B ).
The effect of both inhibitors was then investigated on DC pre-treated with 1-MT before stimulation with LPS. As expected, in presence of SB, DC pre-treated or not by 1-MT were not able to induce IFNγ secretion by T cells. However, in the presence of SB, 1-MT lost its ability to generate DC that could induce IL-5 and IL-13 secretion by T cells (Fig. 5C,D) .
Treating DC with both PD and 1-MT before stimulation with LPS restored their ability to induce IFNγ secretion by T cells, suggesting that the MEK/ERK pathway is involved in the inhibition of Th1-type responses by 1-MT (Fig. 5E ). In contrast, the MEK/ERK pathway did not seem to regulate the ability of DC to induce IL-13 and IL-5 secretion by T cells (Fig. 5F ).
The data suggest that ERK and p38-MAPK can interfere with DC polarization and may be involved in the shift of DC function induced by 1-MT in LPS-activated DC.
Therefore we looked directly at the activation of these two kinases triggered by the different TLR ligands. Activation of p38-MAPK and ERK pathways was determined by the ratio of phosphorylated enzyme to total enzyme by ELISA. In iDC, the treatment with 1-MT alone does not activate ERK and p38 (Fig. 6A,B) . All the TLR ligands increased the ratio of phosphorylated p38 to total p38 although with different strength and kinetics. The pretreatment of DC with 1-MT did not modify the outcome of p38 activation induced by TLR stimulation with pIC while it slightly reduced the level of activation induced by TLR2/6 stimulation without affecting the kinetics (Fig. 6A) . The activation induced by Pam was delayed when cells were pre-treated with 1-MT. The most striking differences were observed with LPS stimulation. p38 phosphorylation still occurred at 5 minutes but was followed by a second and more important peak at 15 minutes (Fig. 6A) .
Like for p38, 1-MT pre-treatment had no effect on ERK phosphorylation following pIC stimulation. ERK phosphorylation was reduced following PGN signaling or delayed Perturbation of these signaling pathways through various adaptors remains to be analyzed in more details.
In conclusion, 1-MT offers a promising tool to study more precisely molecular mechanisms 
